Search Medical Condition
Please enter condition
Please choose location from dropdown

CB B rdoba, Argentina Clinical Trials

A listing of CB B rdoba, Argentina clinical trials actively recruiting patients volunteers.

Found (74) clinical trials

A Study of Baricitinib (LY3009104) in Participants With COVID-19

The reason for this study is to see if the study drug baricitinib is effective in hospitalized participants with COVID-19.

Phase

5.35 miles

Learn More »

A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery

JNJ-70033093 is an oral anticoagulant for prevention and treatment of thromboembolic events (for example, VTE) that binds and inhibits activated form of human coagulation Factor XI (FXIa) with high affinity and selectivity. The study will consist of 3 phases: up to 30-day screening phase before total knee replacement (TKR) surgery, …

Phase

5.39 miles

Learn More »

BAsel Syncope EvaLuation (BASEL IX) Study

Background: Management of patients with syncope is a serious problem concerning 1-2% of emergency department (ED) visits. In 6-20% of these, syncope will be due to a cardiac origin. The rapid and accurate identification of these patients is an important unmet clinical need. Aim: The aim of the study is …

Phase N/A

5.55 miles

Learn More »

Study to Evaluate Cerebral AneurysmFlow Results in Occlusion

AneurysmFlow R1.0 is an approved (CE labeled, cleared in US, Canada and Argentina), software tool intended to provide relevant information on the blood flow in a cerebral aneurysm and its parent artery based on angiography. It provides color coded and vector field representation of a digital subtraction angiography (DSA). It …

Phase N/A

5.55 miles

Learn More »

A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children

This study is a pivotal Phase 2/3 randomized, double-blind, palivizumab-controlled study to evaluate the safety, pharmacokinetics (PK), anti-drug antibody (ADA) response, and descriptive efficacy for MEDI8897 in high-risk infants eligible to receive palivizumab when entering their first or second RSV season (Season 1 or Season 2, respectively). Approximately 1,500 palivizumab-eligible …

Phase

5.88 miles

Learn More »

Sarilumab COVID-19

An individual patient will complete the study approximately 60 days from screening to follow-up on day 60 7 days.

Phase

5.89 miles

Learn More »

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Late Preterm and Term Infants

This pivotal Phase 3 study will determine if MEDI8897 will prevent medically attended RSV-confirmed lower respiratory tract infections (LRTI) in healthy infants entering their first RSV season. The population to be enrolled is healthy late preterm and term infants born 35 weeks 0 days or greater gestational age (GA) who …

Phase

6.17 miles

Learn More »

Organ Donation Survey Among Health Care Professionals in Argentina

The shortage of cadaveric organ donors for transplantation is a global problem. This fact prolongs the time on the waiting list and, therefore, the mortality, which rise to 21.15% in Argentina compared to a world average of 16%. Many reasons can explain the low procurement rate. It has been stated …

Phase N/A

6.18 miles

Learn More »

Medical Education for Better Multiple Sclerosis Outcomes

The goal of the present study is the application of an educational intervention (based on best clinical practices) to reduce therapeutic inertia targeting neurologists caring for MS patients. A secondary goal is to improve physicians' tolerance to uncertainty, which has been directly related to therapeutic inertia in our previous studies. …

Phase N/A

6.26 miles

Learn More »

Rolandic Epilepsy Genomewide Association International Study

Epilepsy is a common neurological disorder affecting 1% of the population. There are over 30 types of epilepsy, some common, some rare. Most epilepsies arise in childhood and have a genetic cause. Approximately 25% of child patients have "Rolandic Epilepsy" or RE, also known as Benign Epilepsy with Centrotemporal Spikes …

Phase N/A

6.27 miles

Learn More »